Advances in immunotherapy are changing treatment ideas and outcomes for certain lung cancer patients. Nationally renowned lung cancer expert David Carbone, MD, explains that several new drugs approved in the last year, which are a totally new class of therapy called immunotherapy, are highly effective and less toxic than standard chemotherapies for some patients with certain tumor markers. This can translate into longer lives and better outcomes for these patients.

What is Immunotherapy for Lung Cancer?

Immunotherapy is a highly-effective drug treatment option for lung cancer. It is less toxic than chemotherapy and, for certain patients, has an improved outcome compared to standard chemotherapy. For certain patients this could mean a much greater survival rate, and a lower probability of requiring chemotherapy in the future.

To learn more about immunotherapy, contact us, or check out our immunotherapy trials for lung cancer patients.